Most Clicked StoriesMore >


Navidea touts new radiotracer for beta amyloid imaging

SNMMI SmartBrief | Jul 27, 2015

Navidea Biopharmaceuticals' fluorine-based radiotracer NAV4694 is now in Phase II and III clinical trials, and company officials say its strong performance coupled with simpler logistics than C-11 Pittsburgh B compound indicate a promising future for the agent. If approved, the radiotracer will be useful in identifying patients for clinical trials and facilitating earlier treatment, said Chief Medical Officer Dr. Michael Tomblyn and Senior Director of Clinical Operations David Colborn. BioPharma Dive (07/24)


18F-NaF PET/CT may beat standard techniques for RCC skeletal lesion detection

SNMMI SmartBrief | Jul 24, 2015

Perma-Fix, Digirad ink deal on new Tc-99m production platform

SNMMI SmartBrief | Jul 28, 2015

Is cancer simply a consequence of life?

SNMMI SmartBrief | Jul 29, 2015

FDA to check safety risk of gadolinium deposits in brain

SNMMI SmartBrief | Jul 28, 2015

Study finds Alzheimer's misdiagnosis carries heavy cost

SNMMI SmartBrief | Jul 29, 2015

Study: Anti-amyloid drug clears buildup, but effect on cognition is unclear

SNMMI SmartBrief | Jul 29, 2015

Navidea radiopharmaceutical study receives grant from NIH

SNMMI SmartBrief | Jul 29, 2015

Study locates area of brain that sets humans apart

SNMMI SmartBrief | Jul 27, 2015

Low glucose metabolism in brain impairs memory performance

SNMMI SmartBrief | Jul 28, 2015


Find SNMMI SmartBrief Issues by Date:



SNMMI News More >


"A Review of Good Clinical Practices for Imaging and Radiation Trials" webinar

SNMMI SmartBrief | Jul 30, 2015

Explore the fundamentals of the physics and technologies of nuclear medicine

SNMMI SmartBrief | Jul 30, 2015

Attention nuclear medicine and diagnostic radiology residents

SNMMI SmartBrief | Jul 29, 2015

The SNMMI-TS Chapter Roadshow is coming to Syracuse, N.Y. -- Aug. 15

SNMMI SmartBrief | Jul 29, 2015

Video: Focus on the Changing Landscape of Health Care

SNMMI SmartBrief | Jul 28, 2015




Sign up for SNMMI SmartBrief



Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession. Learn more